Clinical trial for Cancer
Official title Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
ClinicalTrials.gov ID: NCT07387263
What this study is testing
- What it's testing
- The study wants to see if the app improves patients’ feelings and care experience compared with usual care.
- Who it's for
- It is looking for people newly diagnosed with breast, ovarian, pancreatic, prostate, or colon/GI cancers.
- What's involved
- Participants will use the digital platform to learn about genetics and receive testing, while others receive the usual care. The study compares the two approaches.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Receiving mainstream cancer germline testing related to primary cancer condition (ie.
- 18 years old or older.
- Speak and read English
You likely can't join if
- Receiving genetic testing information via a referral to a genetics clinic
- Do not speak or read English
- Under 18 years of age
- Determined to have diminished, marginal and or fluctuating decisional capacity
- Lack access to internet or an electronic device
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.